Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer

NCT03888612 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer Metastatic

Interventions

DRUG: ARV-110

Sponsor

Arvinas Inc.